
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Chesapeake IRB and Schulman IRB have combined to create Advarra, the provider of IRB, institutional biosafety committee and research compliance services in North America. The new organization will combine expertise in technology, regulatory expertise, and customer service to serve the needs associated with research as well as provide service offerings to medical centers.
Read the full release






